I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 30 studies | 37% ± 15% | |
| astrocyte | 20 studies | 45% ± 19% | |
| fibroblast | 19 studies | 32% ± 12% | |
| macrophage | 15 studies | 39% ± 18% | |
| oligodendrocyte | 15 studies | 47% ± 15% | |
| microglial cell | 15 studies | 47% ± 13% | |
| smooth muscle cell | 15 studies | 26% ± 10% | |
| oligodendrocyte precursor cell | 14 studies | 47% ± 16% | |
| glutamatergic neuron | 12 studies | 64% ± 22% | |
| pericyte | 12 studies | 32% ± 12% | |
| GABAergic neuron | 11 studies | 60% ± 21% | |
| epithelial cell | 11 studies | 38% ± 19% | |
| adipocyte | 10 studies | 44% ± 11% | |
| mast cell | 9 studies | 26% ± 9% | |
| ciliated cell | 9 studies | 33% ± 12% | |
| neuron | 8 studies | 51% ± 17% | |
| myeloid cell | 8 studies | 36% ± 14% | |
| endothelial cell of lymphatic vessel | 8 studies | 37% ± 12% | |
| type I pneumocyte | 8 studies | 38% ± 15% | |
| B cell | 7 studies | 28% ± 10% | |
| dendritic cell | 7 studies | 37% ± 9% | |
| T cell | 7 studies | 29% ± 10% | |
| basal cell | 7 studies | 36% ± 19% | |
| interneuron | 6 studies | 68% ± 21% | |
| retinal ganglion cell | 6 studies | 60% ± 13% | |
| retina horizontal cell | 6 studies | 42% ± 16% | |
| retinal cone cell | 6 studies | 36% ± 10% | |
| myofibroblast cell | 6 studies | 27% ± 12% | |
| type II pneumocyte | 6 studies | 36% ± 9% | |
| natural killer cell | 6 studies | 24% ± 8% | |
| club cell | 6 studies | 34% ± 14% | |
| plasma cell | 5 studies | 29% ± 8% | |
| amacrine cell | 5 studies | 57% ± 12% | |
| retinal rod cell | 5 studies | 37% ± 9% | |
| CD8-positive, alpha-beta T cell | 5 studies | 20% ± 5% | |
| capillary endothelial cell | 5 studies | 25% ± 9% | |
| cardiac muscle cell | 5 studies | 46% ± 10% | |
| mesothelial cell | 5 studies | 36% ± 14% | |
| Mueller cell | 5 studies | 40% ± 14% | |
| regulatory T cell | 5 studies | 20% ± 4% | |
| connective tissue cell | 5 studies | 27% ± 6% | |
| monocyte | 5 studies | 44% ± 11% | |
| goblet cell | 5 studies | 32% ± 25% | |
| secretory cell | 4 studies | 20% ± 5% | |
| non-classical monocyte | 4 studies | 22% ± 4% | |
| granule cell | 4 studies | 49% ± 9% | |
| retinal bipolar neuron | 4 studies | 36% ± 11% | |
| retinal pigment epithelial cell | 4 studies | 43% ± 20% | |
| CD4-positive, alpha-beta T cell | 4 studies | 24% ± 5% | |
| lymphocyte | 4 studies | 33% ± 15% | |
| abnormal cell | 4 studies | 31% ± 18% | |
| endothelial cell of vascular tree | 4 studies | 36% ± 18% | |
| respiratory goblet cell | 4 studies | 42% ± 15% | |
| kidney loop of Henle epithelial cell | 4 studies | 30% ± 9% | |
| renal principal cell | 4 studies | 32% ± 11% | |
| classical monocyte | 3 studies | 21% ± 3% | |
| podocyte | 3 studies | 30% ± 3% | |
| GABAergic interneuron | 3 studies | 64% ± 4% | |
| glial cell | 3 studies | 36% ± 8% | |
| progenitor cell | 3 studies | 35% ± 5% | |
| placental villous trophoblast | 3 studies | 20% ± 3% | |
| platelet | 3 studies | 16% ± 0% | |
| endothelial cell of artery | 3 studies | 21% ± 4% | |
| mononuclear phagocyte | 3 studies | 32% ± 4% | |
| vein endothelial cell | 3 studies | 39% ± 20% | |
| GABAergic amacrine cell | 3 studies | 62% ± 9% | |
| OFF-bipolar cell | 3 studies | 45% ± 3% | |
| ON-bipolar cell | 3 studies | 49% ± 4% | |
| glycinergic amacrine cell | 3 studies | 51% ± 3% | |
| rod bipolar cell | 3 studies | 40% ± 16% | |
| hepatocyte | 3 studies | 59% ± 16% | |
| muscle cell | 3 studies | 43% ± 22% | |
| ependymal cell | 3 studies | 50% ± 17% | |
| enteroendocrine cell | 3 studies | 28% ± 15% | |
| adventitial cell | 3 studies | 25% ± 6% | |
| alveolar macrophage | 3 studies | 53% ± 9% | |
| chondrocyte | 3 studies | 33% ± 4% | |
| leukocyte | 3 studies | 43% ± 10% | |
| transit amplifying cell | 3 studies | 40% ± 34% | |
| plasmacytoid dendritic cell | 3 studies | 20% ± 2% | |
| kidney distal convoluted tubule epithelial cell | 3 studies | 33% ± 11% | |
| renal alpha-intercalated cell | 3 studies | 37% ± 16% | |
| mucus secreting cell | 3 studies | 40% ± 3% |
